Osteoblasts are integral to the development, growth, function, repair and maintenance of bone. The osteoblast forms organic, non-mineralized bone matrix and is involved in complex interactions with a variety of factors, mediators and cell types. Degeneration, pathology, and trauma cause disruption and destruction of the normal skeletal environment and may lead to bone loss.
There is a rise in active populations involved in trauma, elderly patients with fragility fractures and an overall increase in primary, revision and reconstructive bone and joint surgery. Despite the rapid evolution of implant technologies and bone grafting techniques, there is still a great demand for novel bone replacement strategies.
Bone tissue engineering is the state of the art science with the potential to regenerate bone with natural form and function. This review presents the biology of osteoblasts and their current applications in bone tissue engineering biotechnologies and role in stem cell, bioactive factor, recombinant signalling molecule and gene therapy research.
Major trauma care in England. National Audit Office, Report by the Comptroller and Auditor General, HC 213 Session 2009–2010, 5 February 2010.
2.
The care of patients with fragility fractures. British Orthopaedic Association Publications, September 2007.
3.
National Joint Registry of England and Wales, 6th annual report, January 2010.
4.
Gray's anatomy. The anatomical basis of clinical practice, 39th edition (Ed. StandringS.)2005Elsevier Ltd/Churchill Livingstone, London, UK
5.
WolffJ.Über die Wechselbeziehungen zwischen der Form und der Function der Einzelnen Gebilde des Organismus1901FCW Vogel, Leipzig, Germany
6.
EhrlichP. J.LanyonL. E.Mechanical strain and bone cell function: A review. Osteoporosis Int.200213, (9), 688–700
7.
ChenJ. H.Boning up on Wolff's Law: Mechanical regulation of the cells that make and maintain bone. J. Biomech.201043, (1), 108–118
8.
YouL.Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading. Bone200842, (1), 172–179
9.
KobayashiY.UdagawaN.TakahashiN.Action of RANKL and OPG for osteoclastogenesis. Crit. Rev. Eukaryot. Gene Expr.200919, (1), 61–72
10.
ArkinA. M.KatzJ. F.The effects of pressure on epiphyseal growth; the mechanism of plasticity of growing bone. J. Bone Joint Surg. (Am.)195638, 1056–1076
11.
RoblinA. G.CastilloA. B.TurnerC. H.Biomechanical and molecular regulation of bone remodeling. Annu. Rev. Biomed. Engng20068, 455–498
12.
KhanY.LaurencinC. T.Fracture repair with ultrasound: Clinical and cell-based evaluation. J. Bone Joint Surg. (Am.)200890, (Suppl. 1), 138–144
13.
TsunodaM.Treatment of non-union and delayed-union by low intensity pulsed ultrasound. Clin. Calcium200313, (10), 1293–1296
14.
UristM. R.Bone: Formation by autoinduction. Science1965150, 893–899
15.
AlbrektssonT.JohanssonC.Osteoinduction, osteoconduction, and osseointegration. Eur. Spine J.200110, S96–S101
16.
HingK. A.Bone repair in the twenty-first century: Biology, chemistry or engineering?Phil. Trans. R. Soc. Lond.2004362, 2821–2850
Wilson-HenchJ.Osteoinduction. In Progress in biomedical engineering. Vol. 4. Definitions in biomaterialsWilliamsD. F.198729Elsevier, Amsterdam, The Netherlands
19.
UristM. R.The bone induction principle. Clin. Orthop.196753, 243–83
20.
BauerT. W.Bone graft materials: An overview of the basic science. Clin. Orthop.2000371, 10–27
21.
GlantzP. O.Comment. In Progress in biomedical engineering. Vol 4. Definitions in biomaterialsWilliamsD. F.198724Elsevier, Amsterdam, The Netherlands
22.
BrånemarkP. I.Osseointegrated titanium implants in the treatment of the edentulous jaw. Scand. J. Plast. Reconstr. Surg.197711, (Suppl. 16), 1–175
23.
AlbrektssonT.BrånemarkP. I.HanssonH. A.LindströmJ.Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone anchorage in man. Acta Orthop. Scand.198152, 155–170
24.
Dorland's illustrated medical dictionary, 31st edition 2007W. B. Saunders, Philadelphia, Pennsylvania
25.
ZarbG.AlbrektssonT.Osseointegration – a requiem for the periodontal ligament? – An editorial. Int. J. Periodont. Rest. Dentistry199111, 88–91
26.
AlbrektssonT.Principles of osseointegration. In Dental and maxillofacial implantologyHobkirkJ. A.WatsonK.19951–9Mosby-Wolfe, London, UK
27.
CotranR.KumarV.CollinsT.Diseases of immunity. In Robbins Pathologic Basis of Diseases1999188–259W. B. Saunders, Philadelphia, Pennsylvania
28.
LanyonL. E.Control of bone architecture by functional load bearing. J. Bone Miner. Res.19927, 369–375
29.
TurnerC. H.Mechanobiology of the skeleton. Sci. Signal.200928:2, (68), pt3
30.
BovanB. D.SchwartzZ.Response of musculoskeletal cells to biomaterials. J. Am. Acad. Orthop. Surg.200614, (10), S157–S162
31.
YasudaI.Fundamental aspects of fracture treatment. J. Kyoto Med. Soc.19534, 395–404
32.
BassettC. A. L.Biological significance of piezo-electricity. Calcif. Tissue Res.1968I, 252–261
JohanssonC.AlbrektssonT.RoosA.A biomechanical and histomorphometric comparison between differentiated types of bone implants evaluated in a rabbit model. Eur. J. Exp. Musculoskel. Res.19921, 51–61
35.
JohanssonC.A quantitative comparison of machined commercially pure titanium and titanium–aluminum–vanadium implants in rabbit bone. Int. J. Oral Maxillofac. Implants199813, 315–321
36.
FrostH. M.The biology of fracture healing. An overview for clinicians, part I. Clin. Orthop. Rel. Res.1989248, 283–293
37.
FrostH. M.The biology of fracture healing. An overview for clinicians, part II. Clin. Orthop. Rel. Res.1989248, 294–309
38.
AlbrekstonT.The healing of autologous bone grafts after varying degrees of surgical trauma. J. Bone Joint Surg. (Br.)198032, 403–410
39.
TrippelS. E.Growth factors as therapeutic agents. J. Bone Joint Surg. (Am.)199678, 1272–1286
40.
GottlanderM.On hard-tissue reactions to hydroxyapatite-coated titanium implants, PhD Thesis, Department of Biomaterials/Handicap Research, University of Göteborg, Sweden 19941–192
41.
WennerbergA.On surface roughness and implant incorporation, PhD Thesis, Department of Biomaterials/Handicap Research, University of Göteborg, Sweden 19961–212
42.
NilssonL. P.GranströmG.AlbrektssonT.The effect of hyperbaric oxygen treatment of bone regeneration. An experimental study in the rabbit. Int. J. Oral Maxillofac. Implants19873, 43–48
43.
AlbrektssonT.Experimental studies on oxidized implants. A histomorphometrical and biomechanical analysis. Appl. Osseointegration Res.20001, 21–24
44.
AlbrektssonT.On long-term maintenance of the osseointegrated response. Aust. Prosthodont. J.19937, (Suppl.), 15–24
45.
RöserK.A new approach to demonstate cellular activity in bone formation adjacent to implants. J. Biomed. Mater. Res.200051, 280–291
46.
TsuboiN.Histomorphometric analysis of bone–titanium interface in human retrieved implants. In Proceedings of the 3rd International Congress on Tissue Integration in Oral and Maxillofacial ReconstructionUedaM.199684–85Quintessence, Tokyo, Japan
47.
TjellströmA.Osseointegrated titanium implants in the temporal bone. A clinical study on bone-anchored hearing aids. Am. J. Otol.19812, 303–310
AlbrektssonT.The Gothenburg osseointegrated hip arthroplasty: Experience with a novel type of hip design. Clin. Orth. Rel. Res.1998352, 81–94
50.
YoungR. W.Nucleic acids, protein synthesis and bone. Clin. Orthop. Rel. Res.196326, 147–156
51.
Di-SilvioL.GuravN.TsiridisE.Tissue Engineering of bone. In Encyclopedia of biomaterials and biomedical engineering2004, 1:1 1500–1507Marcel Dekker, New York
52.
BruderS. P.FoxB. S.Tissue engineering of bone. Cell based strategies. Clin. Orthop. Relat. Res.1999 October, (367 Suppl.), S68–83
53.
MuschlerG. F.NakamotoC.GriffithL. G.Engineering principles of clinical cell-based tissue engineering. J. Bone Joint Surg. (Am.)200486A, (7), 1541–1558
54.
NgA. M.Comparison of bioengineered human bone construct from four sources of osteogenic cells. J. Orthop. Sci.200510, (2), 192–199
55.
ConnollyJ.Development of an osteogenic bone-marrow preparation. J. Bone Joint Surg. (Am.)198971, 684–691
56.
HernigouP. H.Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J. Bone Joint Surg. (Am.)200587, 1430–1437
57.
CuomoA. V.Mesenchymal stem cell concentration and bone repair: Potential pitfalls from bench to bedside. J. Bone Joint Surg. (Am.)200991, (5), 1073–1083
58.
KaiglerD.Angiogenic and osteogenic potential of bone repair cells for craniofacial regeneration. Tissue Engng Part A201016, (9), 2809–2820
59.
JagerM.Bone marrow concentrate: A novel strategy for bone defect treatment. Curr. Stem Cell Res. Ther.20094, (1), 34–43
60.
MuschlerG. F.Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J. Orthop. Res.200119, (1), 117–125
61.
KuehnleI.GoodellM. A.The therapeutic potential of stem cells from adults. BMJ2002325, (7360), 372–376
62.
El TamerM. K.ReisR. L.Progenitor and stem cells for bone and cartilage regeneration. J. Tissue Engng Regen. Med.20093, (5), 327–337
63.
BajadaS.Updates on stem cells and their applications in regenerative medicine. J. Tissue Engng Regen. Med.20082, (4), 169–183
64.
BiancoP.Multi-potential cells in the bone marrow stroma: Regulation in the context of organ physiology. Crit. Rev. Eukaryot. Gen. Expr.19999, (2), 159–173
65.
VatsA.Stem cells: Sources and applications. Clin. Otolaryngol.200227, (4), 227–232
66.
MarieP. J.FromigueO.Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen. Med.20061, (4), 539–548
67.
DeallerS. F.Electrical phenomena associated with bones and fractures and the therapeutic use of electricity in fracture healing. J. Med. Engng Technol.19815, 73–82
68.
BuchF.On electrical stimulation of bone tissue., PhD Thesis. Department of Biomaterials/Handicap Research, University of Gothenburg, Sweden 19851–139
69.
LevanderG.The study of bone regeneration. Surg. Gynaecol. Obstet.193867, 705–714
70.
HaynesworthS. E.Characterization of cells with osteogenic potential from human bone marrow. Bone199213, 81–88
71.
PittengerM. F.&SetFont Italic=“1”&SetFont Italic=“0”Mesenchymal stem cells in human cell culture. Vol 5. Primary mesenchymal cellsKollerM. R.PalssonB. O.MastersJ. R. W.2001, Ch. 9 189–219Kluwer Academic Publishers, Dordrecht, The Netherlands
72.
ArinzehT. L.Mesenchymal stem cells for bone repair: Preclinical studies and potential orthopaedic applications. Foot Ankle Clin.200510, (4), 651–665
73.
NgM. H.The use of bone marrow stem cells for bone tissue engineering. Med. J. Malaysia200459, (Suppl. B), 41–42
74.
HaynesworthS. E.CarrinoD. A.CaplanA. I.Characterization of the core protein of the large chondroitin sulfate proteoglycan synthesized by chondrocytes in chick limb bud cell cultures. J. Biol. Chem.1987262, (22), 10 574–10 581
75.
JaiswalN.Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem199764, (2), 295–312
LeeK.Cell therapy for bone regeneration – bench to bedside. J. Biomed. Mater. Res. B Appl. Biomater.200989, (1), 252–63
78.
GordeladzeJ. O.From stem cells to bone: Phenotype acquisition, stabilization, and tissue engineering in animal models. ILAR J200951, (1), 42–61
79.
ClinesG. A.Prospects for osteoprogenitor stem cells in fracture repair and osteoporosis. Curr. Opin. Organ. Transplant.201015, (1), 73–78
80.
BernsteinP.Bone tissue engineering in clinical application: Assessment of the current situation. Orthopade200938, (11), 1029–1037
81.
AbdallahB. M.KassemM.Human mesenchymal stem cells: From basic biology to clinical applications. Gene Ther.200815, (2), 109–116
82.
OreffoR. O.TriffittJ. T.Future potentials for using osteogenic stem cells and biomaterials in orthopaedics. Bone199925, (2 Suppl.), 5S–9S
83.
TsiridisE.Enhancing the osteoinductive properties of hydroxyapatite by the addition of human mesenchymal stem cells, and recombinant human osteogenic protein-1 (BMP-7) in vitro. Injury200637, (Suppl. 3), S25–32
84.
TsiridisE.In vitro proliferation and differentiation of human mesenchymal stem cells on hydroxyapaptite versus human demineralized bone matrix with and without osteogenic protein-1. Expert Opinion Biol. Ther.20099, (1), 9–19
85.
Di SilvioL.Addition of human mesenchymal stem cells and osteogenic protein-1 to demineralised bone matrix and insoluble collagenous matrix results in de novo bone formation. J. Bone Joint Surg. (Br.)200890B, (Suppl I), 13–14
86.
TohmaY.Bone marrow-derived mesenchymal cells can rescue osteogenic capacity of devitalized autologous bone. J. Tissue Engng Regen. Med.20082, (1), 61–68
87.
MeijerG. J.Cell based bone tissue engineering in jaw defects. Biomaterials200829, (21), 3053–3061
88.
TsiridisE.In vitro and in vivo optimization of impaction allografting by demineralization and addition of rh-OP-1. J. Orthop. Res.200725, (11), 1425–1437
89.
KordaM.Can mesenchymal stem cells survive under normal impaction force in revision total hip replacements?Tissue Engng200612, (3), 625–630
Di SilvioL.GuravN., In Human cell culture. Vol. 5. Primary mesenchymal cellsKollerM. R.PalssonB. O.MastersJ. R. W.2001, Ch. 11 221–241Kluwer Academic Publishers, Dordrecht, The Netherlands
102.
BalaschJ.Sex steroids and bone; current perspectives. Hum. Reprod. Update20039, (3), 207–222
103.
GentlemanE.Comparative materials differences revealed in engineered bone as a function of cell-specific differentiation. Nature Mater.20098, (9), 763–770
104.
Di SilvioL.In vitro evaluation of the direct effect of estradiol on human osteobalsts (HOB) and human mesenchymal stem cells (H-MSCs). Injury, Int. J. Care Injured200637, (S), S33–S42
105.
XiaojunY.Bioreactor-based bone tissue engineering: The influence of dynamic flow on osteoblast phenotypic expression and matrix mineralization. Proc. Natl Acad. Sci. USA2004101, (31), 11 203–11 208
106.
FrohlichM.Tissue engineered bone grafts: Biological requirements, tissue culture and clinical relevance. Curr. Stem Cell. Res. Ther20083, (4), 254–264
107.
ChangS. C.Ex vivo gene therapy in autologous critical-size craniofacial bone regeneration. Plast. Reconst. Surg.2003112, (7), 1841–1850
108.
SajitaN. K.Mesenchymal stem cell-based therapy: A new paradigm in regenerative medicine. J. Cell. Mol. Med.200913, (11–12), 4385–4402
109.
ChimH.SchantzJ. T.GosainA. K.Beyond the vernacular: New sources of cells for bone tissue engineering. Plast. Reconstr. Surg.2008122, (3), 755–764
110.
HeinoT. J.HentunenT. A.Differentiation of osteoblasts and osteocytes from mesenchymal stem cells. Curr. Stem Cell. Res. Ther.20083, (2), 131–145
111.
KanczlerJ. M.OreffoR. O.Osteogenesis and angiogenesis: The potential for engineering bone. Eur. Cell. Mater.20082, (15), 100–114
112.
SummersB. N.EisensteinS. M.Donor site pain from the ilium: A complication of lumbar spine fusion. J. Bone Joint Surg. (Br.)198971B, 677–680
113.
YoungerE. M.ChapmanM. W.Morbidity at bone graft donor site. J. Orthop. Trauma19893, 192–195
114.
DoiK.TominagaS.ShibataT.Bone grafts with microvascular anastomoses of vascular pedicles. J. Bone Joint Surg. (Am.)197759A, 809–815
115.
BurchardtH.The biology of bone graft repair. Clin. Orthop.1983174, 28–42
116.
VirolainenP.Expression of matrix genes during incorporation of cancellous bone allografts and autografts. Clin. Orthop.1995317, 263–272
117.
AshtonB. A.Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin. Orthop.1980151, 294–299
118.
FriedensteinA. J.Heterotopic transplants of bone marrow: Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation19686, 230–235
119.
MajorsA. K.Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J. Orthop. Res.199715, 546–557
120.
HealeyJ. H.Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. Clin. Orthop.1990256, 280–285
121.
GoldbergV. M.StevensonS.ShafferJ. W.Biology of autografts and allografts. In Bone and cartilage allografts: Biology and clinical applicationsFriedlanderG. E.GoldbergV. M.19913–11The American Academy of Orthopaedic Surgeons, Park Ridge, Illinois
122.
SimondsR. J.HolmbergS. D.HurwitzR. L.Transmission of human immunodeficiency virus type I from a seronegative organ and tissue donor. N. Engl. J. Med.1992326, 726–732
123.
ConradE. U.Transmission of the hepatitis-C virus by tissue transplantation. J. Bone Joint Surg. (Am.)199577A, 214–224
124.
BonfiglioM.JeterW. S.Immunological responses to bone. Clin. Orthop.197287, 19–27
125.
StevensonS.The immune response to osteochondral allografts in dogs. J. Bone Joint Surg.198769A, 573–582
126.
StevensonS.ShafferJ. W.GoldbergV. M.The humoral response to vascular and nonvascular allografts of bone. Clin. Orthop.1996326, 86–95
127.
HorowitzM. C.FriedlaenderG. E.Induction of specific T-cell responsiveness to allogenic bone. J. Bone Joint Surg.199173A, 1157–1168
128.
FriedlaenderG. E.Immune responses to osteochondral allografts. Current knowledge and future directions. Clin. Orthop.1983174, 58–66
129.
BurwellR. G.Studies in the transplantation of bone V. The capacity of fresh and treated grafts of bone to evoke transplantation immunity. J. Bone Joint Surg.196345B, 386–401
130.
KeatingJ. F.McQueenM. M.Review article: Substitutes for autologous bone graft in orthopaedic trauma. J. Bone Joint Surg. (Br.)200183B, 3–8
131.
EnnekingW. F.MindellE. R.Observations on massive retrieved human allografts. J. Bone Joint Surg.199173A, (I), 1123–1142
132.
UristM. R.MikulskiA.LietzeA.Solubilized bone morphogenetic protein. Proc. Natl Acad. Sci. USA197976, 1828–1832
133.
UristM. R.DawsonE.Intertransverse process fusion with the aid of chemosterilized autolyzed allogenic (AAA) bone. Clin. Orthop.1981154, 97–113
134.
TsiridisE.Enhancing the osteoinductive properties of hydroxyapatite by the addition of human mesenchymal stem cells and recombinant human osteogenic protein-1 (BMP-7) in vitro. Injury, Int. J. Care Injured200637S, S25–S32
135.
EinhornT. A.The healing of segmental bone defects induced by demineralized bone matrix. J. Bone Joint Surg.198466A, 274–279
136.
RagniP.LindholmT. S.LindholmT. C.Vertebral fusion dynamics in the thoracic and lumbar spine induced by allogenic demineralized bone matrix combined with autogenous bone marrow. An experimental study in rabbits. Ital. J. Orthop. Traumatol.198713, (24), 241–251
137.
WilkinsR. M.StringerE. A.Demineralized bone powder: Use in grafting space-occupying lesions of bone. Int. Orthop.19942, 71–78
138.
LeeM. Y.Bone allografts are immunogenic and may preclude subsequent organ transplants. Clin. Orthop.1997340, (2), 15–219
ChapmanM. W.BucholzR.CornellC.Treatment of acute fractures with a collagen–calcium phosphate graft material: A randomized clinical trial. J. Bone Joint Surg. (Am.)199779A, 495–502
141.
LarssonS.BauerT. W.Use of injectable calcium phosphate cement for fracture fixation: A review. Clin. Orthop. Relat. Res.2002395, 23–32
142.
TrancikT. M.Allograft reconstruction of the acetabulum during revision total hip arthroplasty. J. Bone Joint Surg.198668A, 527–533
143.
FrankenburgE. P.Biomechanical and histological evaluation of a calcium phosphate cement. J. Bone Joint Surg.199880A, 1112–1124
144.
LeachJ. K.MooneyD. J.Bone engineering by controlled delivery of osteoinductive molecules and cells. Expert Opin. Biol. Ther.20044, (7), 1015–1012
145.
LindM.Growth factors: Possible new clinical tools. Acta Orthop. Scand.199667, 407–417
146.
HauschkaP. V.ChenT. L.MavrakosA. E.Polypeptide growth factors in bone matrix. Ciba Found. Symp.1988136, 207–225
147.
SolheimE.Growth factors in bone. Int. Orthop. (SICOT)199822, 410–416
148.
ChengH.Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J. Bone Joint Surg. (Am.)200385A, (8), 1544–1552
149.
WozneyJ. M.Overview of bone morphogenetic proteins. Spine200227, (16 Suppl. 1), S2–8
150.
MatthewsS. J.Biological activity of bone morphogenetic proteins (BMPs). Injury200536, (Suppl. 3), S34–S37
151.
WangE. A.Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl Acad. Sci. USA199087, (6), 2220–2224
152.
ReddiA. H.Bone morphogenetic proteins: From basic science to clinical applications. J. Bone Joint Surg. (Am.)200183A, (Suppl. 1, Part 1), S1–S6
153.
HeldinC. H.MiyazoneK.ten DijkeP.TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature1997390, (6659), 465–471
154.
WeissR. E.ReddiA. H.Synthesis and localization of fibronectin during collagenous matrix–mesenchymal cell interaction and differentiation of cartilage and bone in vivo. Proc. Natl Acad. Sci. USA198077, (4), 2074–2078
155.
GerstenfeldL. C.Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation. J. Cell. Biochem200388, (5), 873–884
156.
IsraelD. I.Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors199613, 291–300
157.
MayerH.ScuttA. M.AnkenbauerT.Subtle differences in the mitogenic effects of recombinant human bone morphogenetic proteins-2 to -7 DNA synthesis on primary bone-forming cells and identification of BMP-2/4 receptor. Calcif. Tissue Int.199658, 249–555
158.
PhillipsA. M.Overview of the fracture healing cascade. Injury200536, (Suppl. 3), S5–S7
159.
BahamondeM. E.LyonsK. M.BMP3: To be or not to be a BMP. J. Bone Joint Surg. (Am.)200183A, Suppl. 1, S56–S62
160.
ZhangH.BradleyA.Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development1996122, (10), 2977–2986
161.
DudleyA. T.LyonsK. M.RobertsonE. J.A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev.19959, (22), 2795–2807
162.
CentrellaM.Transforming growth factor-beta gene family members and bone. Endocr. Rev.199415, (1), 27–39
